Switzerland Contraceptive Sales is set to reach $67,353,000 by 2026 from $77,670,000 2021, decreased by 0.9% per year. Since 2016, the market increased 0.2% year on year at $2,311,000,000. The country came in number 10 in 2021, Poland overtook $77,670,000. Italy, Argentina and Spain respectively were numbers 2, 3 and 4 in this ranking.
How does Switzerland rank in Contraceptives (Based on Hormones or Spermicides) Market Size Value?
| # | 17 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 483,630,000 | 2023 | -0.78% | -0.58% | View data |
| 2 | 2 Argentina | 368,560,000 | 2023 | +2.14% | +3.2% | View data |
| 3 | 3 Italy | 242,670,000 | 2023 | -8.82% | -9.17% | View data |
| 4 | 4 Spain | 214,090,000 | 2023 | -11.7% | -7.16% | View data |
| 5 | 5 Chile | 123,060,000 | 2023 | -0.61% | -1.89% | View data |
| 6 | 6 Thailand | 74,049,000 | 2023 | -0.41% | +0.22% | View data |
| 7 | 7 Poland | 65,882,000 | 2023 | -6.03% | -4.93% | View data |
| 8 | 8 Switzerland | 62,127,000 | 2023 | -5.57% | -3.62% | |
| 9 | 9 Ukraine | 42,988,000 | 2023 | -0.81% | -0.71% | View data |
| 10 | 10 New Zealand | 28,129,000 | 2023 | +2.59% | +3.2% | View data |